Kepan Chen

1.1k total citations · 2 hit papers
10 papers, 804 citations indexed

About

Kepan Chen is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Kepan Chen has authored 10 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Kepan Chen's work include RNA Interference and Gene Delivery (8 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Immunotherapy and Immune Responses (3 papers). Kepan Chen is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Immunotherapy and Immune Responses (3 papers). Kepan Chen collaborates with scholars based in China, Macao and United States. Kepan Chen's co-authors include Xiangrong Song, Wen Xiao, Na Fan, Shugang Qin, Qian Zheng, Guohong Li, Min Wu, Yuting Chen, Hai Huang and Yuquan Wei and has published in prestigious journals such as Nature Communications, Advanced Functional Materials and Journal of Controlled Release.

In The Last Decade

Kepan Chen

10 papers receiving 789 citations

Hit Papers

mRNA-based therapeutics: powerful and versatile tools to ... 2022 2026 2023 2024 2022 2024 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kepan Chen China 8 619 180 122 105 82 10 804
Michaela Jeong South Korea 8 656 1.1× 121 0.7× 80 0.7× 115 1.1× 65 0.8× 11 816
Jared Beyersdorf United States 9 655 1.1× 133 0.7× 161 1.3× 108 1.0× 42 0.5× 12 836
Allen Yujie Jiang United States 8 856 1.4× 259 1.4× 166 1.4× 121 1.2× 106 1.3× 9 1.1k
Staci Sabnis United States 5 826 1.3× 183 1.0× 152 1.2× 158 1.5× 43 0.5× 6 964
Husain Attarwala United States 11 458 0.7× 131 0.7× 90 0.7× 69 0.7× 117 1.4× 19 760
Timothy Salerno United States 3 705 1.1× 153 0.8× 123 1.0× 133 1.3× 38 0.5× 4 822
Antony Jozić United States 13 939 1.5× 138 0.8× 141 1.2× 142 1.4× 38 0.5× 21 1.1k
Jerry Leung Canada 13 837 1.4× 153 0.8× 104 0.9× 115 1.1× 41 0.5× 23 1.1k
Nuphar Veiga Israel 9 851 1.4× 163 0.9× 78 0.6× 202 1.9× 103 1.3× 10 1.0k
Nikhil Khatwani United States 5 659 1.1× 327 1.8× 131 1.1× 144 1.4× 206 2.5× 6 924

Countries citing papers authored by Kepan Chen

Since Specialization
Citations

This map shows the geographic impact of Kepan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kepan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kepan Chen more than expected).

Fields of papers citing papers by Kepan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kepan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kepan Chen. The network helps show where Kepan Chen may publish in the future.

Co-authorship network of co-authors of Kepan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kepan Chen. A scholar is included among the top collaborators of Kepan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kepan Chen. Kepan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chen, Kepan, Ye Li, Ting Jiang, et al.. (2025). Hydroxychloroquine-functionalized ionizable lipids mitigate inflammatory responses in mRNA therapeutics. Journal of Controlled Release. 387. 114267–114267. 1 indexed citations
2.
Wang, Wei, Kepan Chen, Ting Jiang, et al.. (2024). Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery. Nature Communications. 15(1). 10804–10804. 70 indexed citations breakdown →
3.
Zhang, Yupei, Shugang Qin, Yuting Chen, et al.. (2024). MHCI trafficking signal‐based mRNA vaccines strengthening immune protection against RNA viruses. Bioengineering & Translational Medicine. 10(1). e10709–e10709. 1 indexed citations
4.
Qin, Shugang, Hai Huang, Wen Xiao, et al.. (2023). A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants. Acta Pharmaceutica Sinica B. 13(10). 4291–4304. 10 indexed citations
5.
Peng, Xingchen, Zhaohui Jin, Hai Huang, et al.. (2023). A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma. Nano Research. 16(4). 5357–5367. 26 indexed citations
6.
Qin, Shugang, Yuting Chen, Kepan Chen, et al.. (2022). mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduction and Targeted Therapy. 7(1). 166–166. 476 indexed citations breakdown →
7.
Zhang, Yi, Na Fan, Kepan Chen, et al.. (2022). Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine. Acta Pharmaceutica Sinica B. 13(3). 942–954. 26 indexed citations
8.
Fan, Na, Kepan Chen, Rong Zhu, et al.. (2022). Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants. Science Advances. 8(51). eabq3500–eabq3500. 76 indexed citations
9.
Chen, Kepan, Na Fan, Hai Huang, et al.. (2022). mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids. Advanced Functional Materials. 32(39). 2204692–2204692. 79 indexed citations
10.
Huang, Cheng, Qingqing Tian, Yangmei Ren, et al.. (2022). Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors. Advanced Science. 10(3). e2205532–e2205532. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026